Camp4 Therapeutics Corp (CAMP)
5.41
-0.37
(-6.40%)
USD |
NASDAQ |
Nov 22, 16:00
5.51
+0.10
(+1.85%)
After-Hours: 20:00
Camp4 Therapeutics Shareholders Equity (Quarterly): -158.98M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -158.98M |
| June 30, 2024 | -147.11M |
| Date | Value |
|---|---|
| June 30, 2024 | -147.11M |
| December 31, 2023 | -123.73M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-158.98M
Minimum
Sep 2024
-123.73M
Maximum
Dec 2023
-144.23M
Average
-147.11M
Median
Jun 2024
Shareholders Equity (Quarterly) Benchmarks
| CEL-SCI Corp | 8.473M |
| AIM ImmunoTech Inc | 2.912M |
| IGC Pharma Inc | 7.377M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Protalix BioTherapeutics Inc | 32.44M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 21.36M |
| Total Liabilities (Quarterly) | 180.34M |